Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant574 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,387 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00092495 | Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) | completed | Phase 3 | 3,055 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jan 13, 2015 | clinicaltrials |
| NCT00499031 | Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 38 | Gynecologic Oncology GroupNETWORK | 1 | Jan 13, 2015 | clinicaltrials |
| NCT00012012 |
| Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer |
| completed |
| Phase 1 / Phase 2 |
| 45 |
| Radiation Therapy Oncology GroupNETWORK |
| 1 |
| Jan 7, 2015 |
| clinicaltrials |
| NCT00054444 | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | completed | Phase 1 | 11 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00104910 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 64 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00814086 | Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | completed | Phase 1 | 23 | Gynecologic Oncology GroupNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01492920 | Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy | withdrawn | Phase 3 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Dec 31, 2014 | clinicaltrials |
| NCT00068549 | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | completed | Phase 1 | 13 | Gynecologic Oncology GroupNETWORK | 1 | Dec 25, 2014 | clinicaltrials |
| NCT01294293 | TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer | completed | Phase 1 | 20 | Gynecologic Oncology GroupNETWORK | 1 | Dec 25, 2014 | clinicaltrials |
| NCT02323841 | Feasibility Study: Conservative Treatment in Cervical Cancer | unknown | Early Phase 1 | 30 | Catholic University of the Sacred HeartOTHER | 1 | Dec 24, 2014 | clinicaltrials |
| NCT01777230 | The Value of Preoperative Sentinel Lymph Node Mapping by Pelvic MR Lymphangiography and SPECT-CT in Cervical Cancer | withdrawn | — | 0 | UMC UtrechtOTHER | 1 | Dec 18, 2014 | clinicaltrials |
| NCT00376909 | A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women | completed | Phase 2 | 2,729 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00862810 | Alternate Dosing Schedules Study for HPV Vaccine(ADS) | completed | Phase 4 | 72 | Duke UniversityOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02296255 | Effect of HPV Vaccination on Women Aged 25 Years | completed | Phase 4 | 832 | Cancer Prevention and Research Institute, ItalyOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02280642 | Alternate Dosing Schedules Study for HPV Vaccine (ADS)(ADS) | completed | — | 331 | Duke UniversityOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01937104 | ONSD According to the Position During Laparoscopy(ONSD) | completed | N/A | 60 | Chosun University HospitalOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT00807079 | Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer | completed | Phase 1 / Phase 2 | 12 | ARCAGY/ GINECO GROUPOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT01307774 | Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India | unknown | — | 800 | Purnima MadhivananOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT01372527 | Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT(TopCare) | completed | N/A | 103,870 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT01723956 | Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women(VICAR2) | completed | N/A | 166 | University of Witwatersrand, South AfricaOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT01588301 | Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention(APACHE-2) | completed | Early Phase 1 | 5,998 | University Hospital, ToursOTHER | 0 | Sep 12, 2014 | clinicaltrials |
| NCT02237326 | Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women(SAVE) | completed | N/A | 654 | University of California, San FranciscoOTHER | 1 | Sep 11, 2014 | clinicaltrials |
| NCT00682552 | Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence | terminated | N/A | 14 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00548418 | Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer | completed | Phase 2 | 27 | Washington University School of MedicineOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01405768 | Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) | completed | Phase 2 | 56 | Washington University School of MedicineOTHER | 1 | Jul 28, 2014 | clinicaltrials |
| NCT02198365 | Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia | completed | — | 250 | Cathay General HospitalOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00610662 | Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear | withdrawn | — | 0 | British Columbia Cancer AgencyOTHER | 1 | Jul 21, 2014 | clinicaltrials |
| NCT02184975 | Cold Knife Conization With and Without Lateral Hemostatic Sutures | completed | Phase 2 | 100 | Barretos Cancer HospitalOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00626561 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2014 | clinicaltrials |
| NCT00835679 | Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | terminated | Early Phase 1 | 9 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00003094 | Carotenoid Rich Diet in Treating Cervical Dysplasia | withdrawn | Phase 2 | 0 | University of California, San DiegoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT00295945 | Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer | completed | — | 240 | University of California, San FranciscoOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01097252 | Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer | completed | Phase 3 | 104 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01194609 | A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer | terminated | Phase 1 / Phase 2 | 2 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00916500 | Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer | completed | Phase 2 | 71 | Korea Cancer Center HospitalOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT01338051 | The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru(PERCAPS) | completed | Phase 1 | 642 | Preventive Oncology International, Inc.OTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02116920 | HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening(PODBT) | unknown | — | 1,000 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 17, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00101192 | Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | completed | Phase 2 | 76 | Gynecologic Oncology GroupNETWORK | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01613521 | Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 13, 2014 | clinicaltrials |
| NCT01671462 | European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System | completed | — | 1,365 | Becton, Dickinson and CompanyINDUSTRY | 2 | Feb 20, 2014 | clinicaltrials |
| NCT00087113 | Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00967928 | Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer | withdrawn | Phase 1 | 0 | Accelerated Community Oncology Research NetworkOTHER | 0 | Feb 14, 2014 | clinicaltrials |
| NCT01755585 | Irradiation Modulates the Pharmacokinetics of Anticancer Drugs | unknown | — | 40 | Far Eastern Memorial HospitalOTHER | 0 | Jan 22, 2014 | clinicaltrials |
| NCT01403103 | Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer | withdrawn | Early Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Jan 17, 2014 | clinicaltrials |
| NCT00003065 | Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix | completed | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT02018003 | The Effect of Postoperative Therapy on the Quality of Life of Patients With Early Cervical Cancer Research | unknown | — | 180 | Peking UniversityOTHER | 0 | Dec 23, 2013 | clinicaltrials |
| NCT01837303 | chemQbiosciences:Manual Liquid Based Cytology | completed | — | 76 | University of North Carolina, Chapel HillOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01999933 | Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer | unknown | Phase 2 / Phase 3 | 600 | Mei ShiOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT01035580 | Trial on Safety and Pharmacokinetics of Intravaginal Curcumin | completed | Phase 1 | 13 | Emory UniversityOTHER | 1 | Nov 28, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jan 13, 2015source: clinicaltrials